NCT01862991View on ClinicalTrials.gov

Pre-Operative Effects of Mifepristone on Dilation and Evacuation Services

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Legally Induced Abortion Without Mention of Complication
Interventions
OTHER

Hygroscopic cervical dilators

Dilapan-S osmotic cervical dilators inserted through the internal os.

DRUG

Misoprostol

400 mcg buccal misoprostol 90 pre-op

DRUG

Intra-amniotic digoxin

1mg digoxin administered intra-amniotically \~24 hours pre-op in patients that are greater than 22 weeks gestation

DRUG

Mifepristone

200 mcg Mifepristone orally

Trial Locations (2)

94305

Stanford University Medical Center, Stanford

95128

Santa Clara Valley Medical Center, San Jose

All Listed Sponsors
collaborator

Santa Clara Valley Medical Center

OTHER

lead

Stanford University

OTHER

NCT01862991 - Pre-Operative Effects of Mifepristone on Dilation and Evacuation Services | Biotech Hunter | Biotech Hunter